MILAN, April 7, 2015 /PRNewswire/ --
- Change at the top for the leading provider of medicines authentication
Renato Angelini is the new Managing Director of Aegate Italy, a leading provider of medicines authentication services which has been operating in Italy and throughout Europe with the largest digital platform in the world for the real time control of medicinal products.
Angelini aims to further develop the company and its innovative services in Italy. The Aegate system is already integrated in 90% of Italian pharmacies and enables a direct, interactive communication between the pharmacist and pharmaceutical companies. Aegate ensures the authenticity of drugs, blocks withdrawn or expired medicines and transmits information and messages via the pharmacist to provide a better service to the patient.
Angelini brings sales and market research experience from Artsana Chicco SpA, the MET Group, Medipragma and Dendrite. More recently, he was Head of the Customer information Business Unit at Cegedim Italy.
"I am excited about my assignment in Aegate, a company operating in the healthcare sector in such an innovative way," Renato Angelini said. "Aegate, thanks to its digital real-time network, can immediately inform all stakeholders in the pharma supply chain to enhance the skills of the pharmacist and improve the patients' health. This is a huge potential I will encourage through collaboration with key stakeholders in the sector in Italy."
"Renato Angelini's appointment coincides with a phase of further rapid development for Aegate in Italy, with a growing pharmacy and pharmaceutical commercial service," Mark De Simone, CEO of Aegate, said. "With its digital interaction channel, Aegate made possible the immediate verification of 2.7 billion packs of medicines, providing pharmacists and patients with the best information at point of dispensing - thus protecting more than 17 million patients across Europe. Renato will have the important task of enhancing our services and activities in Italy, a strategic country for us."
With a documented history of some 3 billion medicines scanned to date with an average rate of 200,000 transactions per hour across 15,000 dispensing points, Aegate is the principal active market leader in medicines verification. Aegate's Reach, Assure and Protect services meet the needs of all stakeholders. Supported internationally by manufacturers and pharmacists alike, Aegate is a European company with offices throughout Europe. Our mission is to protect patients from falsified, recalled or expired medicines. We operate a highly secure real‐time system to verify the authenticity of medicines. This operates seamlessly from manufacturer to pharmacy, and fully meets the requirements of the European legislation for falsified medicines. The Aegate network also supports messaging services that provide additional information for the pharmacist at the point of dispense, such as regulatory or drug safety advice and patient education or adherence information. For more information on Aegate, please visit http://www.aegate.com
Media contact information:
Head of Marketing & Communications